Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation
Open Access
- 14 October 2003
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (8), 1433-1438
- https://doi.org/10.1038/sj.bjc.6601311
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Chemo-Radiotherapy For Localized Pancreatic Cancer: Increased Dose Intensity and Reduced Acute Toxicity with Concomitant Radiotherapy and Protracted Venous Infusion 5-FluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1998
- A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral CancerAnnals of Surgery, 1994
- The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-upThe Lancet, 1994
- Patterns of failure following curative resection of gastric carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Randomized comparison of R1 and R2 gastrectomy for gastric carcinomaBritish Journal of Surgery, 1988
- A phase II study of cisplatin in advanced gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Precision radiotherapy for cancer of the pancreas: Technique and resultsInternational Journal of Radiation Oncology*Biology*Physics, 1980